Tyra Biosciences Inc

Tyra Biosciences, Inc. is a clinical-stage biotechnology company striving to develop targeted therapies for oncology patients with limited options. Operating primarily in the global biotechnological field, it centres on genomic-enabled, precision oncology drug discovery and development. Within the biotechnology sector, Tyra aims to deliver landmark oncology therapeutics to patients globally. Driven by a commitment to undermine cancer's complexity, it leverages precision technologies to develop potent and selective precision drug candidates. Tyra’s network of dynamic partnerships is pivotal in accelerating the development of its cancer treatments. Monitor the TYRA share price by adding it to your eToro watchlist.